Generic Drug Approval Process and Accessibility
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the…
Why Are Some Generic Drugs Skyrocketing In Price?
2014-11-20T13:00:00-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJkZWZhdWx0c1wvQ2FwaXRvbF9kZWZhdWx0LWltYWdlLmpwZyIsImVkaXRzIjp7InJlc2l6ZSI6eyJmaXQiOiJjb3ZlciIsImhlaWdodCI6NTA2fX19
This video was obtained from the Congressional Committee's website and may be encoded at a different quality than C‑SPAN uses for hearings covered with its own cameras. Also, the video might not start at the beginning of the hearing and much of the data normally added to C‑SPAN.org for committee hearings may not be available.
Report Video IssueHosting Organization
Related Video
-
-
Patent Settlements for Generic Drugs
Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The…
-
Generic Drug Marketplace
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also…
-
Costs of HIV/AIDS Medicines
Witnesses testified on the cost of HIV/AIDS medications and monopolies created in the HIV/AIDS drugs market. The focus…